Timothy Stenzel News Today

Democrats sent drug pricing provisions of their reconciliation package to the Senate parliamentarian this week.

Experts highlight better government-industry coordination as key to ramping testing in future pandemics but question if recent progress will prove enduring.

A preview released by the White House indicates a proposal to address prescription drug costs will be sandwiched between an array of remarks about the broader economy.

While many senators have not yet publicly stated how they'd vote, some key Republicans haven't ruled out supporting Califf.

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. With Katherine Ellen Foley, Rachel Roubein and Emily Martin. On Tap — The U.S. will send about 75 percent of its next batch of Covid sho...

Sanofi, GSK launch late stage trial for Covid jab — DoD names testing coordinating hubs

Chris Lo 8 April 2021 (Last Updated April 8th, 2021 12:37) After more than a year since the emergence of Covid-19, the global road to recovery will be a long and challenging one. What are the key lessons that life sciences companies can take away from the world’s pandemic year? While the startlingly rapid development and rollout of vaccines has brought the prospect of a light at the end of a very dark tunnel, the world still ...

Health Canada has approved two more rapid tests that can indicate the prevalence of COVID-19 immunity, devices experts say should be used judiciously but can help ensure the success of vaccines.

Modern Healthcare Illustration / Getty Images With rapid antigen tests for SARS-CoV-2 slow to come to market, officials at the US Food and Drug Administration have tried to signal via a number of public comments that the agency would be flexible regarding test performance requirements and use models. These indications of flexibility have largely failed to speed development and commercialization of rapid antigen tests, however, as test vendors, wary of falling short of agency requirements, have ...

Health Canada has approved two more rapid tests that can indicate the prevalence of COVID-19 immunity, devices experts say should be used judiciously but can help ensure the success of vaccines.